Fake docs, real jobs: Pharmacist at Community Health Centre in Ballia booked in recruitment scam Ruchika Sharma1 Oct 2025 2:18 PM ISTBallia: A pharmacist and a postal assistant have been booked after being accused of using fake appointment letters to secure government jobs...
Wockhardt seeks USFDA approval for Zidebactam-Cefepime injection to treat Serious GramNegative Infections Ruchika Sharma1 Oct 2025 1:00 PM ISTMumbai: Wockhardt has announced the submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (US FDA) for its novel...
Biocon Biologics, Amgen strike settlement, clear path for Bosaya, Aukelso in US Ruchika Sharma1 Oct 2025 12:05 PM ISTBengaluru: Biocon Biologics Ltd., a fully integrated global biosimilars company and subsidiary of Biocon Ltd., has announced a settlement...
Lupin bags USFDA approval for Rivaroxaban for Oral Suspension for thromboprophylaxis in pediatric patients Ruchika Sharma1 Oct 2025 11:37 AM ISTMumbai: Global pharma major Lupin Limited has announced that it has received approval from the United States Food and Drug Administration (USFDA) for...
Indian Immunologicals Launches Raksha-IBR, India's First DIVA Vaccine Against IBR Parthika Patel30 Sept 2025 3:24 PM ISTHyderabad: In a major breakthrough for the livestock sector, Indian Immunologicals Limited (IIL) has rolled out India's first gE-deleted DIVA marker...
Rajasthan Drug Official Under Probe for Misreporting Spurious Medicines Parthika Patel30 Sept 2025 3:16 PM ISTJaipur: A senior official from Rajasthan's Food Safety and Drug Control Commissionerate (FSDCC) is under investigation for allegedly misreporting...
Intas Pharma Told to Narrow Margins, Extend Duration in Pembrolizumab Trial Protocol Farhat Nasim30 Sept 2025 3:09 PM ISTNew Delhi: The Subject Expert Committee (SEC) under the Central Drugs Standard Control Organisation (CDSCO) has directed Intas Pharmaceuticals Ltd. to...
AbbVie to Launch Ovarian Cancer Drug ELAHERE in UK at US Price Levels Parthika Patel30 Sept 2025 2:57 PM ISTNew Delhi: AbbVie has announced that it will launch its ovarian cancer drug ELAHERE (mirvetuximab soravtansine-gynx) in the United Kingdom at a list...
Kala Bio Halts Eye Drug Development After Phase 2b Trial Failure Parthika Patel30 Sept 2025 2:49 PM ISTNew Delhi: KALA BIO, Inc. a clinical-stage biopharmaceutical company focused on eye diseases, announced that its CHASE Phase 2b trial for KPI-012 in...
Novartis commences tender offer to buy Tourmaline Bio Ruchika Sharma30 Sept 2025 2:47 PM ISTBasel: Novartis has announced that Torino Merger Sub Inc., a Delaware corporation and an indirect wholly owned subsidiary of Novartis, has...
AstraZeneca to harmonise its listing structure across LSE, STO and NYSE Ruchika Sharma30 Sept 2025 12:00 PM ISTCambridge: AstraZeneca plans to harmonise its share listing structure to deliver a global listing for global investors in a global company. The...
JnJ Tremfya gets USFDA nod for pediatric plaque psoriasis, active psoriatic arthritis Ruchika Sharma30 Sept 2025 11:03 AM ISTHorsham: Johnson & Johnson has announced that the U.S. Food and Drug Administration (FDA) has approved TREMFYA (guselkumab) for the treatment...
